欧洲心脏骤停登记研究三(EuReCa-THREE):欧洲院前急救反应时间对结局的影响
EuReCa-THREE是一项国际、前瞻性、登记为基础的队列研究,2022年9月1日至11月30日收集28个国家数据,主要评估急救反应时间间隔及其对结局的影响。在45,251例确诊院前心脏骤停中,32,033例由急救医疗服务(EMS)治疗(开始或继续复苏)。平均反应时间为12.2分钟(范围6.4-22.8),25%的患者在7分钟内被到达。EMS治疗病例中,任何自主循环恢复(ROSC)率为31.2%(范围17.0-42.7),存活至急诊科交接(存活事件)为22.5%(范围12.3-25.5),总生存率为7.5%(范围3.1-35.0),发病率为4.0/10万居民(范围1.7-24.6)。结论指出欧洲院前心脏骤停的发病率、管理和结局持续存在差异,对于EMS治疗的患者,结果提示反应时间与生存可能性之间存在明确关联。
要点
- 在32,033例EMS治疗的院前心脏骤停患者中,任何ROSC率为31.2%(范围17.0-42.7)。
- EMS治疗患者中,存活至急诊科交接(存活事件)率为22.5%(范围12.3-25.5)。
- EMS治疗患者总生存率为7.5%(范围3.1-35.0),发病率为4.0/10万居民(范围1.7-24.6)。
- 平均EMS反应时间为12.2分钟(范围6.4-22.8),仅25%的患者在7分钟内被到达。
- 研究结果提示EMS反应时间与院前心脏骤停患者生存可能性之间存在明确关联。
适用人群与场景
- 28个国家中经EMS治疗的院前心脏骤停患者(复苏开始或继续),数据收集时间为2022年9月1日至11月30日。
研究设计与关键结果
- 研究类型:国际、前瞻性、登记为基础的队列研究;样本量:45,251例确诊院前心脏骤停,其中32,033例由EMS治疗;数据来自28个国家。
- 平均EMS反应时间为12.2分钟(范围6.4-22.8),25%的患者在7分钟内被到达。
- EMS治疗患者中,任何ROSC率为31.2%(范围17.0-42.7),存活至急诊科交接(存活事件)率为22.5%(范围12.3-25.5),总生存率为7.5%(范围3.1-35.0)。
- 院前心脏骤停发病率为4.0/10万居民(范围1.7-24.6)。
- 结果提示EMS反应时间与生存可能性之间存在明确关联。
证据类型、等级与局限
- 证据类型:国际、前瞻性、登记为基础的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 研究结果提示EMS反应时间与院前心脏骤停患者生存可能性之间存在明确关联,欧洲各地区的发病率、管理和结局存在持续差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Throughout Europe there are important differences in the structure and characteristics of Emergency Medical Services (EMS) and their response to out-of-hospital cardiac arrest (OHCA). The primary aim of EuReCa-THREE was to examine the epidemiology of cardiac arrest in Europe and explore the association between EMS response time and survival.
METHODS: EuReCa-THREE was an international, prospective, registry-based, cohort study, for which data were collected from 1 September to 30 November 2022 from 28 countries. Primary research questions were focused on assessing time intervals and their impact on outcomes.
RESULTS: Of the 45,251 confirmed OHCA cases, 32,033 were treated by the EMS i.e. resuscitation started or continued. The mean response time was 12.2 min (range 6.4-22.8), with 25% of patients were reached within 7 min. For all cases where resuscitation was started or continued by EMS, the rate of any ROSC was 31.2% (range 17.0-42.7), ROSC sustained until arrival at the emergency department and transfer of care (survived event) was 22.5%(range 12.3-25.5) and overall survival was 7.5% (range 3.1-35.0), (incidence 4.0 per 100,000 inhabitants, range 1.7-24.6).
CONCLUSION: The results of EuReCa-THREE highlight continuing variation in the incidence, management and outcomes from OHCA across Europe. For patients who were EMS-treated, results indicate clear associations between response times and the likelihood of survival.
参考来源
- Gräsner JT, Wnent J, Lefering R, et al. European registry of cardiac arrest study THREE (EuReCa- THREE) - EMS response time influence on outcome in Europe. Resuscitation. 2025. PMID: 40633749. doi:10.1016/j.resuscitation.2025.110704
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。